Home | Contact Us | FAQ | Search & Site Map | Link to Us
Sign In | Join | Other 45 Sites in Network
Home
Discussion Groups
General
GeneralCardiologyVisionDentistryPharmacyLaboratoryNutritionAlternative
Diseases and Disorders
AIDSAlzheimer'sArthritisAsthmaCancerBreast CancerDiabetesEpilepsyGlaucomaHepatitisHerpesLupusProstate BPHProstate CancerProstatitisSinusitisTinnitus

Medical Forum / Diseases and Disorders / Cancer / March 2004

Tip: Looking for answers? Try searching our database.

Basal cell nodular type on nose

Thread view: 
Enable EMail Alerts  Start New Thread
Thread rating: 
D&G - 16 Nov 2003 17:30 GMT
Hi I am new to this group.  Just diagnosed with a basal cell carcinoma
(non-sclerotic type) on the tip of my nose.  I am a redhead and new it was
inevitable.  Just not so soon, and not on the tip of my nose.
I am debating on treatment type.  Cryo vs. Mohs vs. 5-fu vs. etc.  Can any
one give me any advise on treatment type and results.  I am female and I'm
very concerned about reoccurrence and scarring.  HELP.

Thanks,
Gin
Sharon - 16 Nov 2003 17:34 GMT
"D&G" <dgmagr@swbell.net> wrote in message
> Cryo vs. Mohs vs. 5-fu vs. etc.  Can any
> one give me any advise on treatment type and results.  I am female and I'm
> very concerned about reoccurrence and scarring.  HELP.
I have never experienced this disease but my Uncle John is a "two time
hitter".  You can see a pic of him here:
http://www.rare-cancer.org/person1.html
and a little of his story here:
http://www.rare-cancer.org/three.html#john

His MOH's went very well and I do not see a lot of scarring.  My Uncle John
has always told me that he is willing to share his experience with anyone
that it would help.  Would you like me to give you his email addie?

Take Care,  Sharon
J - 17 Nov 2003 07:07 GMT
> "D&G" <dgmagr@swbell.net> wrote in message
> > Cryo vs. Mohs vs. 5-fu vs. etc.  Can any
[quoted text clipped - 5 lines]
> and a little of his story here:
> http://www.rare-cancer.org/three.html#john

I saw nothing whatsoever there of assist to the poster except a one-sentence PS
about your uncle's basal cell..
Basal cell carcinoma is not rare.
Basal cell carcinoma is the most common form of cancer in the US. It accounts
for about 75% of all skin cancers.
So what's your point in posting those, Sharon?
Looking for donations?
J
Sharon - 17 Nov 2003 12:15 GMT
"J" <BigWink@invalid.inv> wrote in message > So what's your point in posting
those, Sharon?
> Looking for donations?
> J
The point was to let her see what my Uncle looked like after the MOH's.  And
to let her see that he really did have BCC.   You would have to drill down
pretty far in that website to see the donations links.  And that link only
takes you to other rare cancer websites for their research links.  I didn't
send her any of those links, I sent her to specific pages, so she wouldn't
have to bother with the rest of the website.  Take Care, Sharon
J - 16 Nov 2003 20:45 GMT
> Hi I am new to this group.  Just diagnosed with a basal cell carcinoma
> (non-sclerotic type) on the tip of my nose.  I am a redhead and new it was
> inevitable.  Just not so soon, and not on the tip of my nose.
> I am debating on treatment type.  Cryo vs. Mohs vs. 5-fu vs. etc.  Can any
> one give me any advise on treatment type and results.  I am female and I'm
> very concerned about reoccurrence and scarring.  HELP.

Hello Gin,
What's the size? When do you need to make your decision?
Have you had scarring problems before?
Have you talked to a dermy or surgeon for an opinion?

Steph should be along...

Earlier he replied "A dermatologist or a surgeon if you like the idea of
surgery. I would see a
radiation oncologist every time...."

Hang in there for Steph, if you can.

J
Steph - 17 Nov 2003 03:12 GMT
> > Hi I am new to this group.  Just diagnosed with a basal cell carcinoma
> > (non-sclerotic type) on the tip of my nose.  I am a redhead and new it was
[quoted text clipped - 17 lines]
>
> J

You already gave my answer, J
Peter Moran - 17 Nov 2003 06:48 GMT
> > > Hi I am new to this group.  Just diagnosed with a basal cell carcinoma
> > > (non-sclerotic type) on the tip of my nose.  I am a redhead and new it
[quoted text clipped - 22 lines]
>
> You already gave my answer, J

Radiotherapy in the long term usually leaves a depressed, pale, thin,
telangiectatic scar and has at least as high a recurrence rate as surgery.
Our local radiotherapists no longer treat cutaneous BCCs, but that may be
due to volume of work in Australia.

I would see a good plastic surgeon if you want the best long term .

Peter Moran.
Steph - 17 Nov 2003 08:08 GMT
> > > > Hi I am new to this group.  Just diagnosed with a basal cell carcinoma
> > > > (non-sclerotic type) on the tip of my nose.  I am a redhead and new it
[quoted text clipped - 31 lines]
>
> Peter Moran.

As I've always said, good radiotherapy or good surgery is the best treatment
for BCC.

I see a lot of recurrences after bad surgery......

And all the literature suggests that patients find the cosmetic result after
RT every bit as good or better than after surgery.
Peter Moran - 17 Nov 2003 20:49 GMT
> "Peter Moran" <moringa@gil.com.au> wrote in message

news:3fb86f50$0$15338$61c65585@uq-127creek-reader-02.brisbane.pipenetworks.com.au...

> > > > > Hi I am new to this group.  Just diagnosed with a basal cell
> carcinoma
[quoted text clipped - 41 lines]
>
> I see a lot of recurrences after bad surgery......

I agree with that.  But the recurrence rate should be near zero with surgery
for a simple nodular BCC.

> And all the literature suggests that patients find the cosmetic result after
> RT every bit as good or better than after surgery.

I also agree with that at any early follow up. But refer me to such a study
at ten, twenty, or thirty years.

Peter Moran
Steph - 18 Nov 2003 03:14 GMT
> > "Peter Moran" <moringa@gil.com.au> wrote in message

news:3fb86f50$0$15338$61c65585@uq-127creek-reader-02.brisbane.pipenetworks.com.au...

> > > > > > Hi I am new to this group.  Just diagnosed with a basal cell
> > carcinoma
[quoted text clipped - 49 lines]
> I agree with that.  But the recurrence rate should be near zero with surgery
> for a simple nodular BCC.

As it should be with radiotherapy..........

> > And all the literature suggests that patients find the cosmetic result
> after
[quoted text clipped - 4 lines]
>
> Peter Moran

Ditto, Peter
Peter Moran - 18 Nov 2003 21:43 GMT
> "Peter Moran" <moringa@gil.com.au> wrote in message

news:3fb9344a$0$15338$61c65585@uq-127creek-reader-02.brisbane.pipenetworks.com.au...

> > > "Peter Moran" <moringa@gil.com.au> wrote in message

<snip>

> > > And all the literature suggests that patients find the cosmetic result
> > after
[quoted text clipped - 7 lines]
>
> Ditto, Peter

OK. The following randomised trial demonstrates what I suggest, that the
cosmetic outcome with radiotherapy deteriorates with time.

.Evaluation of cosmetic results of a randomized trial comparing surgery and
radiotherapy in the treatment of basal cell carcinoma of the face.

Petit JY, Avril MF, Margulis A, Chassagne D, Gerbaulet A, Duvillard P,
Auperin A, Rietjens M.

Plastic Surgery Department, European Institute of Oncology, Milan, Italy.
jypetit@ieo.cilea.it

Basal cell carcinoma is the most frequent cutaneous carcinoma, and it is
characterized by its local spreading and an exceptional tendency to
metastasize. Radical excision or destruction ensures the highest chance of
cure. The most frequent site of this tumor is the face, where radical
excision is limited by the proximity of essential anatomic structures. The
main difficulty is to avoid mutilation and to provide good cosmetic results
despite the vicinity of the eyes, the nose, and the mouth. Surgery and
radiotherapy are known to provide similar chances of cure, but results
concerning cosmetic sequelae are controversial, depending sometimes on the
specialty of the physician in charge of the treatment. A randomized trial
was performed at the Gustave-Roussy Institute to compare basal cell
carcinomas of the face treated either by surgery or by radiotherapy. In
summary, a significant advantage was observed in favor of surgery, as has
been published elsewhere. Looking at the details of the cosmetic results, we
analyzed the specific methodology of the cosmetic evaluation set up to
eradicate the usual bias owing to subjective judgments. We looked also to
the evolution of the cosmetic results with time. A panel of five judges
performed repeated evaluations during the follow-up, and standardized
photographs were taken at each visit and rated later by three nonmedical
judges. In total, 174 patients were treated by surgery and 173 by
radiotherapy; the choice of the treatment was allocated by randomization.
Postoperative complications were higher in the radiotherapy group. The final
cosmetic results after 4 years of follow-up were rated significantly better
with surgery than with radiotherapy (good in 87 percent versus 69 percent
according to the patient, 79 percent versus 40 percent according to the
dermatologist, and respectively for each of the observers). Evolution of the
ratings during the follow-up demonstrated an improvement of the cosmesis
after surgery and stable or deteriorated results after radiotherapy. The
same trend was observed regardless of the site of the tumor on the face,
except for the nose, where the difference--still in favor of the
surgery--was not significant. Concordance of all assessments in our study
was the main guarantee of reliability of our methodology for cosmetic
evaluation.

     Another for good luck.    The face heals very well and scars tend to
disappear with time.   There can be no question that the changes I described
increase with time after radiotheapy.

     Br J Cancer. 1997;76(1):100-6.  Related Articles, Links

Comment in:
 a.. Br J Cancer. 1998 Nov;78(9):1257.

Basal cell carcinoma of the face: surgery or radiotherapy? Results of a
randomized study.

Avril MF, Auperin A, Margulis A, Gerbaulet A, Duvillard P, Benhamou E,
Guillaume JC, Chalon R, Petit JY, Sancho-Garnier H, Prade M, Bouzy J,
Chassagne D.

Service de dermatologie, Institut Gustave Roussy, Villejuif, France.

Basal cell carcinomas (BCCs) are very frequent cutaneous cancers, often
located on the face. Cure rates with surgery and radiotherapy are high, but
these treatments have never been compared prospectively. A randomized trial
was initiated in 1982 to compare surgery and radiotherapy in the treatment
of primary BCC of the face measuring less than 4 cm. The primary end point
was the failure rate (persistent or recurrent disease) after 4 years of
follow-up. The secondary end point was the cosmetic results assessed by the
patient, the dermatologist and three persons not involved in the trial. In
the course of the trial, 347 patients were treated. Of the 174 patients in
the surgery group, 71% had local anaesthesia and 91% frozen section
examination. Of the 173 patients in the radiotherapy group, 55% were treated
with interstitial brachytherapy, 33% with contactherapy and 12% with
conventional radiotherapy. The 4-year actuarial failure rate (95% CI) was
0.7% (0.1-3.9%) in the surgery group compared with 7.5% (4.2-13.1%) in the
radiotherapy group (log-rank P = 0.003). The cosmetic results assessed by
four of the five judges were significantly better after surgery than after
radiotherapy. Eighty-seven per cent of the surgery-treated patients and 69%
of the radiation-treated patients considered the cosmetic result as good (P
< 0.01). Thus, in the treatment of BCC of the face of less than 4 cm in
diameter, surgery should be preferred to radiotherapy.

Peter Moran
doe - 18 Nov 2003 22:04 GMT
>Subject: Re: Basal cell nodular type on nose

Carcinogenesis. 2003 Mar;24(3):555-63.  Related Articles, Links  

 
Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic
death of prostate carcinoma DU145 cells: modulation of CDKI-CDK-cyclin and
pRb-related protein-E2F complexes.

Singh RP, Agarwal C, Agarwal R.

Department of Pharmaceutical Sciences, School of Pharmacy and University of
Colorado Cancer Center, University of Colorado Health Sciences Center, Denver,
CO 80262, USA.

Cancer chemopreventive effects of inositol hexaphosphate (IP6), a dietary
constituent, have been demonstrated against a variety of experimental tumors,
however, limited studies have been done against prostate cancer (PCA), and
molecular mechanisms are not well defined. In the present study, we
investigated the growth inhibitory effect and associated mechanisms of IP6 in
advanced human PCA cells. Advanced human prostate carcinoma DU145 cells were
used to study the anticancer effect of IP6. Flow cytometric analysis was
performed for cell cycle progression and apoptosis studies. Western
immunoblotting, immunoprecipitation and kinase assay were performed to
investigate the involvement of G1 cell cycle regulators and their interplay,
and end point markers of apoptosis. A significant dose- as well as
time-dependent growth inhibition was observed in IP6-treated cells, which was
associated with an increase in G1 arrest. IP6 strongly increased the expression
of CDKIs (cyclin-dependent kinase inhibitors), Cip1/p21 and Kip1/p27, without
any noticeable changes in G1 CDKs and cyclins, except a slight increase in
cyclin D2. IP6 inhibited kinase activities associated with CDK2, 4 and 6, and
cyclin E and D1. Further studies showed the increased binding of Kip1/p27 and
Cip1/p21 with cyclin D1 and E. In down-stream of CDKI-CDK/cyclin cascade, IP6
increased hypophosphorylated levels of Rb-related proteins, pRb/p107 and
pRb2/p130, and moderately decreased E2F4 but increased its binding to both
pRb/p107 and pRb2/p130. At higher doses and longer treatment times, IP6 caused
a marked increase in apoptosis, which was accompanied by increased levels of
cleaved PARP and active caspase 3. IP6 modulates CDKI-CDK-cyclin complex, and
decreases CDK-cyclin kinase activity, possibly leading to hypophosphorylation
of Rb-related proteins and an increased sequestration of E2F4. Higher doses of
IP6 could induce apoptosis and that might involve caspases activation. These
molecular alterations provide an insight into IP6-caused growth inhibition, G1
arrest and apoptotic death of human prostate carcinoma DU145 cells.

PMID: 12663518 [PubMed - indexed for MEDLINE]

--------------------------------------------------------------------------
------

Who loves ya.
Tom
Signature

Jesus Was A Vegetarian! http://jesuswasavegetarian.7h.com
Man Is A Herbivore! http://pages.ivillage.com/ironjustice/manisaherbivore
DEAD PEOPLE WALKING http://pages.ivillage.com/ironjustice/deadpeoplewalking

Steph - 19 Nov 2003 02:22 GMT
> > "Peter Moran" <moringa@gil.com.au> wrote in message

news:3fb9344a$0$15338$61c65585@uq-127creek-reader-02.brisbane.pipenetworks.com.au...

> > > > "Peter Moran" <moringa@gil.com.au> wrote in message
> > >
[quoted text clipped - 98 lines]
>
> Peter Moran

Peter,
It's the same group of patients in both studies!
This is a very unusual group of patients "Of the 173 patients in the
radiotherapy group, 55% were treated with interstitial brachytherapy, 33%
with contactherapy and 12% with conventional radiotherapy." Over half the
patients had interstitial brachytherapy. In BC, less than 0.5% of patients
with skin cancers are treated by interstitial brachytherapy (which is
surgery, by the way, as well as radiotherapy). And less than 1% of skin
cancers treated by radiotherapy are treated by interstitial.  Have you seen
the size of a caesium needle? I'm not surprised by these silly results in a
silly study
Peter Moran - 19 Nov 2003 20:28 GMT
> "Peter Moran" <moringa@gil.com.au> wrote in message
> news:3fba9264$0$29936$61c65585@uq-127creek-reader-> >
[quoted text clipped - 5 lines]
> with contactherapy and 12% with conventional radiotherapy." Over half the
> patients had interstitial brachytherapy.

I did miss that sentence.   I agree this is odd, unless they were dealing
with a lot of bulky tumours, which is possible in Italy.

I don't think it necessarily  contradicts the conclusions.

Not surprisingly there are no other randomised studies that i can find on
the question, so we are left with a difference of opinion, and possibly us
each seeing the results of different techniques, although few sites in the
world would have more experience and expertise in the treatment of  BCCa as
the QRI in Brisbane, Australia.   I must ask if you have you had the
opportunity to see any of your personal results ten, fifteen years, twenty
years  down the track?     The effects of radiotherapy on the skin evolve
forever.

Peter Moran
Steph - 20 Nov 2003 06:40 GMT
> > "Peter Moran" <moringa@gil.com.au> wrote in message
> > news:3fba9264$0$29936$61c65585@uq-127creek-reader-> >
[quoted text clipped - 21 lines]
>
> Peter Moran

Yes, I see plenty of patients 10, 15 and 20 years after radiotherapy. Most
of them are very pleased with the results, and come back for other tumours
to be treated.
I also see a steady stream of recurrences after Moh's magical mystery
treatment. And after Moh's for a large BCC, with a skin graft in place, the
cosmesis is terrible, and recurrences are deep and noticed late, by which
time they are often fixed to the underlying skull or facial bones and are a
bugger to treat.......

The "trial" you found is the only one I could find going back to 1960,
Peter. I think it's the only randomised study. But whatever it says, it has
very little to do with the bread and butter of treating BCCs and SCCs of
less than 4 cm in size.

The effects of radiotherapy may evolve forever in some people, but so do the
effects of ageing. There are many patients who had radiotherapy 10 or more
years ago for small skin cancers in whom I can't even find the area
treated..........
madiba - 20 Nov 2003 18:40 GMT
> "Peter Moran" <moringa@gil.com.au> wrote in message
> > OK. The following randomised trial demonstrates what I suggest, that the
> > cosmetic outcome with radiotherapy deteriorates with time.
DeVita has said this for decades..

<snip>

> > Peter Moran
>
[quoted text clipped - 8 lines]
> radiotherapy are treated by interstitial.  Have you seen the size of a
> caesium needle? I'm not surprised by these silly results in a silly study
These studies were done by the french who have a long history of very
elegant brachytherapy of skin tumours. They threaded thin (Ra?) wires
s.c., the results were also cosmetically very good. Nowdays I imagine
they thread thin catheters s.c. to take small Ir-192 sources..

Signature

madiba

D&G - 19 Nov 2003 22:06 GMT
Hi J

It seems to be about a 1cm x 1cm (approximately)  It is hard to see, it is
very faint.  But its on the tip of my nose.
I need to make a decision as soon as possible. I have not had a huge problem
with scaring, but I am a surgical nurse and I see the things we do in the
OR.  I have talked to one dermatologist and many surgeons from plastic to
general to ENT.  I get a huge difference of opinion so I wanted to talk to
someone that might have experienced it first hand.  I go to see an
ENT/Plastic tomorrow for another OFFICIAL opinion.
Thanks
Gin

> > Hi I am new to this group.  Just diagnosed with a basal cell carcinoma
> > (non-sclerotic type) on the tip of my nose.  I am a redhead and new it was
[quoted text clipped - 17 lines]
>
> J
Sharon - 19 Nov 2003 21:58 GMT
"D&G" <dgmagr@swbell.net> wrote in message
>I get a huge difference of opinion so I wanted to talk to
> someone that might have experienced it first hand.  I go to see an
> ENT/Plastic tomorrow for another OFFICIAL opinion.
> Thanks
> Gin

I had emailed before, but I will just tell you once again Gin.  My Uncle had
the MOH's surgery for his basal cell carcinoma.  My Mom also had a carcinoma
removed surgically from her nose.  My Mom's experience is limited, since she
does not ask questions or keep track of info.  Ski-jump noses run in my
family.  Even with sunblock, they get burned.

In any event, my Uncle John has always told me that he is willing to talk to
any patient that he can help with information.  Would you like to have his
email addie.  If so, email me privately and I will send it privately.  I do
not want him to be inundated with newgroup spamming.  Please take the 'spam'
out of my addie when you email.

Take Care,  Sharon
Steph - 20 Nov 2003 06:42 GMT
> Hi J
>
[quoted text clipped - 8 lines]
> Thanks
> Gin

It wouldn't do any harm to get and "official" opinion from a radiation
oncologist either! Dermatologists and surgeons are pretty free with their
opinions on what radiation can and cannot do, usually without knowing much
about the subject...
doe - 20 Nov 2003 07:07 GMT
>Subject: Re: Basal cell nodular type on nose

>Oncologists are pretty free with their
>opinions  usually without knowing much
...

Couldn't have said it better myself ..

Who loves ya.
Tom

Signature

Jesus Was A Vegetarian! http://jesuswasavegetarian.7h.com
Man Is A Herbivore! http://pages.ivillage.com/ironjustice/manisaherbivore
DEAD PEOPLE WALKING http://pages.ivillage.com/ironjustice/deadpeoplewalking

Mike Radcliffe - 20 Nov 2003 07:32 GMT
> >Subject: Re: Basal cell nodular type on nose
>
[quoted text clipped - 6 lines]
> Who loves ya.
> Tom

Strikes me they know about oncology and radiation and can read and
understand simple english unlike some iron deficient spammers I know.
MIKE
doe - 20 Nov 2003 09:10 GMT
>Subject: Re: Basal cell nodular type on nose
>From: "Mike Radcliffe" mikeradcliffenospam@bigpond.com
[quoted text clipped - 15 lines]
>understand simple english unlike some iron deficient spammers I know.
>MIKE

As if you could compete ..

F .. O ..

Who loves ya.
Tom
Signature

Jesus Was A Vegetarian! http://jesuswasavegetarian.7h.com
Man Is A Herbivore! http://pages.ivillage.com/ironjustice/manisaherbivore
DEAD PEOPLE WALKING http://pages.ivillage.com/ironjustice/deadpeoplewalking

Mike Radcliffe - 20 Nov 2003 07:19 GMT
> > Hi J
> >
[quoted text clipped - 14 lines]
> opinions on what radiation can and cannot do, usually without knowing much
> about the subject...

In Fremantle Australia the ENT clinic sees all the cancer patients in one
session one day a week and is attended in one room by the oncologist,
radiation oncologist, ent and plastic surgeons. All options and opinions can
be advanced and discussed. It's a bit daunting for patients to see so many
specialists at one time but at least all medical opinions are represented at
one time and saves the patient having to slog around looking for different
opinions....if they even knew there were different opinions to be had.
 I know the chest clinics have the same sort of system for their patients.
I think the same is true for other hospitals in the the area but if it isn't
it should be and should be universal in cultures boasting advanced medical
amenities.
I don't know if other medical specialties like gastroenterology,
dermatology, genito-urology etc have the same system but it would seem to be
almost criminal not to.
MIKE
doe - 20 Nov 2003 09:10 GMT
>Subject: Re: Basal cell nodular type on nose
>From: "Mike Radcliffe"

<<snip>>

Who loves ya.
Tom
Signature

Jesus Was A Vegetarian! http://jesuswasavegetarian.7h.com
Man Is A Herbivore! http://pages.ivillage.com/ironjustice/manisaherbivore
DEAD PEOPLE WALKING http://pages.ivillage.com/ironjustice/deadpeoplewalking

madiba - 20 Nov 2003 20:04 GMT
>  I don't know if other medical specialties like gastroenterology,
> dermatology, genito-urology etc have the same system but it would seem to
> be almost criminal not to.
Oh its very 'en vogue' in the UK, rad. oncologists spend lots of their
time in such meetings. Leaves little time for proper treatment
planning.. Its still catching on in the continental EU.

Signature

madiba

Mike Radcliffe - 21 Nov 2003 08:41 GMT
> >  I don't know if other medical specialties like gastroenterology,
> > dermatology, genito-urology etc have the same system but it would seem to
> > be almost criminal not to.
> Oh its very 'en vogue' in the UK, rad. oncologists spend lots of their
> time in such meetings. Leaves little time for proper treatment
> planning.. Its still catching on in the continental EU.

  Treatment planning is of no value unless the appropriate treatment is
agreed upon in the first place.
   Most radiation oncologists have plenty of time to plan treatment; it's
lack of machine time that is usually the problem, I am fairly sure.
MIKE
Steph - 21 Nov 2003 16:32 GMT
> > >  I don't know if other medical specialties like gastroenterology,
> > > dermatology, genito-urology etc have the same system but it would seem
[quoted text clipped - 9 lines]
> lack of machine time that is usually the problem, I am fairly sure.
> MIKE

We do all the team political correctness stuff in BC.
It doesn't cut into clinical time, just breakfast and lunch and
supper............
madiba - 22 Nov 2003 14:23 GMT
> > > >  I don't know if other medical specialties like gastroenterology,
> > > > dermatology, genito-urology etc have the same system but it would seem
[quoted text clipped - 8 lines]
> >     Most radiation oncologists have plenty of time to plan treatment; it's
> > lack of machine time that is usually the problem, I am fairly sure.
No, also serious med. manpower shortages, but Tony B is working on the
problem (both aspects)..
> > MIKE
> >
> We do all the team political correctness stuff in BC.
> It doesn't cut into clinical time, just breakfast and lunch and
> supper............
LOL
On the Continent nothing is more important than the lunch break..
Signature

madiba

madiba - 20 Nov 2003 20:04 GMT
> Hi J
>
[quoted text clipped - 6 lines]
> someone that might have experienced it first hand.  I go to see an
> ENT/Plastic tomorrow for another OFFICIAL opinion.
Radiotherapy is most suitable for nose tip tumors.  Peter Moran has a
valid point about long-term cosmetic results after RT and being located
in Australia he presumably has a vast amount of experience with this
cancer. However its difficult to get good surgical results at certain
locations on the face, so ask whoever you go to which method brings the
best results at your tumor site.

Signature

madiba

Peter Moran - 20 Nov 2003 20:14 GMT
> > Hi J
> >
[quoted text clipped - 12 lines]
> locations on the face, so ask whoever you go to which method brings the
> best results at your tumor site.

I agree with this. A BCC of this size on the tip of the nose will probably
need a full thickness skin graft, with variable, but often poor cosmetic
outcomes.   This is an instance where radiotetherapy, if available,   will
give better results in the short term.

Peter Moran
madiba - 28 Mar 2004 23:39 GMT
> "madiba" <down@thekraal.com> wrote in message

> > Radiotherapy is most suitable for nose tip tumors.  Peter Moran has a
> > valid point about long-term cosmetic results after RT and being located
> > in Australia he presumably has a vast amount of experience with this
> > cancer. However its difficult to get good surgical results at certain
> > locations on the face, so ask whoever you go to which method brings the
> > best results at your tumor site.

> I agree with this. A BCC of this size on the tip of the nose will probably
> need a full thickness skin graft, with variable, but often poor cosmetic
> outcomes.   This is an instance where radiotetherapy, if available,   will
> give better results in the short term.

There is now a 5% Imiquimod creme (Aldara®) available that does the job
by stimulating the immune response to destroy the BCC. Very good results
with superficial lesions, also with solar keratoses and all kinds of
warts (HPV). Less promising with melanoma and deep tumors.

Signature

madiba

J - 17 Nov 2003 07:07 GMT
> Hi I am new to this group.  Just diagnosed with a basal cell carcinoma
> (non-sclerotic type) on the tip of my nose.  I am a redhead and new it was
> inevitable.  Just not so soon, and not on the tip of my nose.
> I am debating on treatment type.  Cryo vs. Mohs vs. 5-fu vs. etc.  Can any
> one give me any advise on treatment type and results.  I am female and I'm
> very concerned about reoccurrence and scarring.  HELP.

Gin, since you seem to be in the south US, you'd do well to wear a wide
brimmed hat and avoid the sun during peak hours and/or over-exposures. oh and
make sure that someone, from time to time, checks your scalp and other areas
that you cannot see.
http://www.nlm.nih.gov/medlineplus/ency/article/000824.htm
J
D&G - 19 Nov 2003 22:13 GMT
Hi J

Yes I am in my early 40's I have worn sunscreen on my face, neck, chest, and
arms everyday for 20 years.  Mostly I avoid the sun completely.  I run from
shade to shade.  This ca is probably due to damage done when I was a child
(before sunscreen and the media push for it.) Great advice although.
As for checking my skin . . . I will see my dermo every 6 mo from now on.
Wish I would have started earlier.

Thanks again,
Gin

> > Hi I am new to this group.  Just diagnosed with a basal cell carcinoma
> > (non-sclerotic type) on the tip of my nose.  I am a redhead and new it was
[quoted text clipped - 9 lines]
> http://www.nlm.nih.gov/medlineplus/ency/article/000824.htm
> J
Tm n Kat - 18 Nov 2003 01:52 GMT
>Subject: Basal cell nodular type on nose
>From: "D&G" dgmagr@swbell.net
>Date: 11/16/2003

>Hi I am new to this group.  Just diagnosed with a basal cell carcinoma
>(non-sclerotic type) on the tip of my nose.  I am a redhead and new it was
[quoted text clipped - 5 lines]
>Thanks,
>Gin

I went to a plastic surgeon whose office was adjacent to a hospital.Sent the
biopsy over and got the (margin) results before he closed the wound.  That
worked well for me but it was a small enough area where he could do it in his
office.  Dr Dean Odeal was just talking about his experience on his radio show
this past weekend and he had the Mohs procedure.  Kathy J
Ron Peterson - 25 Nov 2003 19:44 GMT
> Hi I am new to this group.  Just diagnosed with a basal cell carcinoma
> (non-sclerotic type) on the tip of my nose.  I am a redhead and new it was
> inevitable.  Just not so soon, and not on the tip of my nose.
> I am debating on treatment type.  Cryo vs. Mohs vs. 5-fu vs. etc.  Can any
> one give me any advise on treatment type and results.  I am female and I'm
> very concerned about reoccurrence and scarring.  HELP.

I have had Moh's chemosurgery a few times and have been pleased with
the results. The advantage of Moh's technique is that a minimal amount
of tissue is removed which results in less scarring. I haven't had any
reoccurance at those sites, but am pretty good about wearing sunblock.

Signature

  Ron

 
Sign In
Join
My Latest Posts
My Monitored Threads
My Blog
My Photo Gallery
My Profile
My Homepage

Start New Thread
Enable EMail Alerts
Rate this Thread



©2008 Advenet LLC   Privacy Policy - Terms of Use
This website includes both content owned or controlled by Advenet as well as content owned or controlled by third parties.